Archives

Loading Events

Diabetic Kidney Disease: What Does It Mean For Patients?

Thank you for attending, we hope you enjoyed this webinar.

Please tell us what you thought about today’s presentation by taking the survey below:

Diabetic Kidney Disease: What Does It Mean For Patients?

Background Diabetes Mellitus (DM) frequently causes CKD and is called diabetic kidney disease (DKD).1 DKD progresses more rapidly with type 2 diabetes than type1.2 Every 24 hours, 170 patients with diabetes begin kidney replacement therapy.1

Did You Know?

  • One in three adults diagnosed with diabetes has chronic kidney disease.1
Why Attend This Webinar?
  • During this webinar, Dr Lerma and Michael Filsinger will discuss an overview of diabetic kidney disease (DKD) and what it means for patients who have been diagnosed with DKD. They will explore the pathophysiology, risk factors, common tests and studies, as well as helpful recommendations and management options.
  What You Will Learn
  • Overview of DKD
  • Modifiable and Non-Modifiable Risk Factors of DKD
  • Routine Testing for DKD and CKD
  • Medical Management and Recommendations for Treatment
  References:
  1. Diabetes and Chronic Kidney Disease. Centers for Disease Control and Prevention (CDC). https://www.cdc.gov/diabetes/managing/diabetes-kidney-disease.html Updated December 2022. Accessed January 2024.
  2. Diabetic Kidney Disease: Diagnosis, Treatment, and Prevention. American Family Physician. https://www.aafp.org/pubs/afp/issues/2019/0615/p751.html Published June 2019. Accessed January 2024.

Edgar Lerma

Edgar Lerma, MD

Clinical Professor of Medicine, Section of Nephrology, University of Illinois at Chicago

University of Illinois at Chicago*

Edgar Lerma, MD, earned his Doctor of Medicine from the University of Santo Tomas Faculty of Medicine and Surgery in Manila, Philippines. He completed Residency Training in Internal Medicine at UIC/Mercy Hospital and Medical Center, where he also served as Chief Resident. He completed a Fellowship in Nephrology and Hypertension at Northwestern Memorial Hospital, the Feinberg School of Medicine at Northwestern University, and the Veterans Administration Lakeside Medical Center in Chicago, Illinois.

Dr Lerma is a Diplomate in the Subspecialty of Nephrology with the American Board of Internal Medicine. He has authored more than 100 peer-reviewed publications and presentations; notable publications include Current Diagnosis & Treatment: Nephrology & Hypertension, Nephrology Secrets, and Henrich’s Principles and Practice of Dialysis. He has peer reviewed and served on editorial boards for numerous journals, and currently is Associate Editor for International Urology and Nephrology, Clinical Reviews in Bone and Mineral Metabolism, and Journal of Clinical Lipidology.

At present, he holds the rank of Clinical Professor of Medicine with the Section of Nephrology at University of Illinois at Chicago. He serves as the Educational Coordinator for Nephrology with UIC/Advocate Christ Medical Center.

In recognition of his clinical work and expertise, Dr Lerma has been elected to Fellowship of the American College of Physicians, Fellowship of the American Society of Nephrology, Fellowship of the American Heart Association/ Council on Kidney in Cardiovascular Disease, Fellowship of the American Society of Hypertension, Fellowship of the National Lipid Association, Fellowship of the National Kidney Foundation, and Fellowship of the American Society of Diagnostic and Interventional Nephrology. He has also been recognized for teaching and has been the recipient of “Subspecialty Teaching Attending Physician of the Year” in 2006 and “Physician Recognition Award for Excellence in Academics” in 2011 from UIC/Advocate Christ Medical Center Internal Medicine Residency Training Program.

Dr Lerma’s research interests include CKD, hypertension, bone and mineral disorders, and dyslipidemias in CKD.

Michael Filsinger

Michael Filsinger, MPA, PA-C

Nephrology Medical Science Liaison

Otsuka Pharmaceutical Development & Commercialization, Inc.*

Michael Filsinger, MPA, PA-C is a Medical Science Liaison at Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Michael earned his Bachelor of Health Care Sciences as well as Master of Physician Assistant at Duquesne University in Pittsburgh, PA. Following his graduate training, Michael went on to complete a Pediatric Surgery Residency at Children’s National Medical Center in Washington, DC Prior to joining Otsuka, Michael spent the last 15 years working in solid organ transplant in Charlotte, NC where he developed a passion for improving the care of patients with renal disease and ESKD.

*Dr Edgar Lerma is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Michael Filsinger is an employee of OPDC.

Registration

Please Log In Or Join to Register for this Event.

Related Resources

Join Today for Instant Access to all NephU Offerings.

Membership is free!

Join NephU today at no cost to register for this event and access to other premium content.

  • The NephU Community is collaborating to improve care and the future outcomes for individuals with kidney disease and other related conditions.
  • Quickly learn more about the topics that interest you.
  • Access our library of on-demand kidney health resources
  • Gain key insights from industry experts & though leaders.